Revolution Medicines, Inc.: cashflow_financing

Value{"amount": 90187000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2019-01-01 – 2019-06-30
Statuscurrent
EntityRevolution Medicines, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-20-038663 · Open the official SEC filing →
Retrieved: 2026-08-19T16:44:54.531503+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001628171/cashflow-financing/2019-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4584b7d4-67f0-4d4a-aa6a-2018d59e51cf

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies